Trump Administration appears to have ended its US trade probe into pharmaceutical imports, according to End Point News

The termination of the trade probe into pharmaceutical imports signals a potential easing of trade tensions, which could reduce uncertainty for the sector and improve investor sentiment.

Newsquawk StaffPublished On the live feed at 6 more headlines followed before this page went public
Newsquawk headlinesUTC

US President Trump's envoy secretly met Iran's exiled crown prince, Reza Pahlavi, to discuss the Iran protests; Pahlavi is trying to position himself to step in as a "transitional" leader if the regime falls, via Axios

[MARKET UPDATE]: Crude complex sees upside amid punchy Trump Iran rhetoric

Trump Administration appears to have ended its US trade probe into pharmaceutical imports, according to End Point News

US sells USD 22bln of 30-year bonds; Stop through 0.8bps

US President Trump when asked about help on the way to Iran, says you are going to find out; good idea if Americans evacuate from Iran

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

The Department of Commerce appears to have concluded its Section 232 investigation into Pharmaceutical imports, according to a new document reviewed by Endpoints News.

Context

This may provide some support for USD across FX markets, particularly against risk-sensitive currencies, while also positively impacting equities in the healthcare space. Traders should watch for any shifts in market sentiment, as this move could be seen as a stabilizing factor in U.S. trade relations.

Related headlines

The whole workspace, free to try.

Try it free